Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises IK Partners in the divestment of Carspect to TÜV SÜD
Mandate

Vinge advises IK Partners in the divestment of Carspect to TÜV SÜD

August 19, 2024 Banking and Finance M&A Financial Regulatory Real Estate and Construction Employment and Benefits Intellectual Property Commercial Agreements Automotive, Mobility and Electrification

Vinge has advised IK Partners and the other owners in connection with the divestment of Carspect Group Holding AB to TÜV SÜD Aktiengesellschaft. Carspect is a leading provider of vehicle inspections in Sweden, Estonia and Latvia, with a total of approximately 150 stations and over 500 employees.

Vinge's team consisted primarily of Jonas Bergström, Johanna Wiberg, Vilhelm Rondahl and Ida Appelgren (M&A), Lionardo Ojeda, Rebecka Margolin, Sofia Haggren and Nour Makie (Banking and Finance), ohan Cederblad (Permits & Accreditation), Kristoffer Larsson (Real Estate & Environment), Ebba Svenburg and Emil Lindwall (Employment Law), Martin Boström (Commercial Contracts / IT), Felizia Wiker (IP) and Anna Ekdahl Roos, Ellinore Boström Andersson and Gabriella Balbo (Transaction Support).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026